Toxicity Profiling of Biosurfactants Produced by Novel Marine Bacterial Strains by Voulgaridou, Georgia-Persephoni et al.
 International Journal of 
Molecular Sciences
Article
Toxicity Profiling of Biosurfactants Produced by Novel Marine
Bacterial Strains
Georgia-Persephoni Voulgaridou 1, Theodora Mantso 2, Ioannis Anestopoulos 1 , Ariel Klavaris 1,
Christina Katzastra 1, Despoina-Eugenia Kiousi 1, Marini Mantela 1, Alex Galanis 1 , Konstantinos Gardikis 3,




Citation: Voulgaridou, G.-P.; Mantso,
T.; Anestopoulos, I.; Klavaris, A.;
Katzastra, C.; Kiousi, D.-E.; Mantela,
M.; Galanis, A.; Gardikis, K.; Banat,
I.M.; et al. Toxicity Profiling of
Biosurfactants Produced by Novel
Marine Bacterial Strains. Int. J. Mol.
Sci. 2021, 22, 2383. https://doi.org/
10.3390/ijms22052383
Academic Editor: Gerardo Prieto
Received: 9 February 2021
Accepted: 23 February 2021
Published: 27 February 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis,
Greece; gvoulgar@mbg.duth.gr (G.-P.V.); i.anestopoulos@yahoo.com (I.A.); arielklvrs@hotmail.com (A.K.);
christine.katzastra@gmail.com (C.K.); dkiousi@mbg.duth.gr (D.-E.K.); marimant6@hotmail.com (M.M.);
agalanis@mbg.duth.gr (A.G.)
2 Department of Applied Sciences, Northumbria University, Newcastle Upon Tyne NE1 8ST, UK;
theodora066@hotmail.com
3 Research and Development Department, APIVITA SA, Industrial Park Markopoulo Mesogaias,
19003 Athens, Greece; gardikis-k@apivita.com
4 Pharmaceutical Science Research Group, Biomedical Science Research Institute, Ulster University, Coleraine,
Northern Ireland BT52 1SA, UK; im.banat@ulster.ac.uk
5 Institute of Mechanical, Process & Energy Engineering, School of Engineering & Physical Sciences,
Heriot-Watt University, Edinburgh EH14 4AS, UK; tony.gutierrez@hw.ac.uk
6 Institute of Biological Chemistry, Biophysics & Bioengineering, School of Engineering & Physical Sciences,
Heriot-Watt University, Edinburgh EH14 4AS, UK; k.salek@hw.ac.uk (K.S.); S.R.Euston@hw.ac.uk (S.E.)
7 The Cyprus Institute of Neurology and Genetics, Department of Cancer Genetics, Therapeutics and
Ultrastructural Pathology, Nicosia 2371, Cyprus
8 The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, PO Box 23462,
Nicosia 1683, Cyprus
* Correspondence: mihalisp@cing.ac.cy (M.I.P.); apappa@mbg.duth.gr (A.P.); Tel.: +357-22392626 (M.I.P.);
+30-25510-30625 (A.P.)
Abstract: Surface active agents (SAAs), currently used in modern industry, are synthetic chemicals pro-
duced from non-renewable sources, with potential toxic impacts on humans and the environment. Thus,
there is an increased interest for the identification and utilization of natural derived SAAs. As such, the
marine environment is considered a promising source of biosurfactants with low toxicity, environmental
compatibility, and biodegradation compared to their synthetic counterparts. MARISURF is a Horizon
2020 EU-funded project aiming to identify and functionally characterize SAAs, derived from a unique
marine bacterial collection, towards commercial exploitation. Specifically, rhamnolipids produced
by Marinobacter MCTG107b and Pseudomonas MCTG214(3b1) strains were previously identified and
characterized while currently their toxicity profile was assessed by utilizing well-established methodolo-
gies. Our results showed a lack of cytotoxicity in in vitro models of human skin and liver as indicated
by alamar blue and propidium iodide assays. Additionally, the use of the single gel electrophoresis
assay, under oxidative stress conditions, revealed absence of any significant mutagenic/anti-mutagenic
potential. Finally, both 2,2’-azino-bis (3-ethylbenzothiazoline-6-sulphonicacid) (ABTS) and 2,2-diphenyl-
1-picrylhydrazyl radical (DPPH) cell-free assays, revealed no significant anti-oxidant capacity for neither
of the tested compounds. Consequently, the absence of significant cytotoxicity and/or mutagenicity
justifies their commercial exploitation and potential development into industrial end-user applications
as natural and environmentally friendly biosurfactants.
Keywords: surface active agents; marine biosurfactants; toxicity profiling; antioxidant activity;
anti-mutagenic activity; cytotoxicity; Marinobacter strains; Pseudomonas strains; in vitro skin model;
in vitro liver model
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1. Introduction
Surface active agents attribute their name to their ability to adsorb to gas-liquid,
liquid-liquid as well as solid-liquid interfaces [1]. This is possible due to the amphipathic
characteristics of SAAs, which possess a hydrophobic tail and a hydrophilic head. Being
amphiphilic, these molecules can partition their hydrophilic moiety towards the aqueous
phase and their hydrophobic moiety towards the non-soluble phase, thus acting as emulsi-
fiers as well as foaming, dispersion, and wetting agents [2]. Due to these properties, SAAs
are extremely important for cosmetic, pharmaceutical, detergent, and food industries [3].
The vast majority of SAAs used in industry today are synthetic, chemical surfactants.
However, due to the environmental effects of these non-degradable SAAs, research has
been focused on searching for novel, biodegradable, environmental-friendly, and natural-
derived SAAs [4]. These molecules are called biosurfactants and are mainly derived
from microorganisms, particularly from bacteria, yeasts, and filamentous fungi. They are
often characterized by high biodegradability, increased tolerance to temperature and pH
variations, low toxicity, high biocompatibility, and enhanced emulsifying properties [5].
Biosurfactants can be both polymeric and non-polymeric compounds and include fatty
acids, glycolipids, lipopeptides, liposaccharides, and neutral lipids [6–8]. Apart from
their ability to reduce surface and interfacial tension, they often have the potential to
interact, both specifically and nonspecifically, with biological molecules, most commonly
lipid membranes and proteins. Consequently, they exhibit a panel of bioactivities such as
antioxidant, anti-microbial, anti-cancer, anti-aging, and anti-inflammatory properties [9,10].
The health promoting properties of biosurfactants are of great importance for cosmeceutical
and food industries, as they are often desirable by the consumers and thus can facilitate
the promotion of these products.
Over the past few years, a vast number of new biosurfactants have been isolated from
the marine environment. Indeed, marine bacteria have emerged as a valuable source of
novel SAAs. Interestingly, marine bacteria that have been identified to produce biosur-
factants were mostly found in oil spills. This finding is not surprising, considering the
ability of biosurfactant-synthetizing bacteria to produce emulsifiers allowing them to use
the hydrophobic hydrocarbon oils as alternative food sources [4].
MARISURF EU Horizon 2020 project aimed to identify novel, naturally derived SAAs
from a unique marine bacterial collection and functionally characterize them with respect
to different desirable commercial properties. Following the initial screening process, two
novel bacterial strains, MCTG107b and MCTG214(3b1), were identified to produce rham-
nolipids with properties of enhanced surface tension reduction for potential commercial
exploitation. The screening, cultivation process, identification, and isolation of these bio-
surfactants has been described in detail in previous reports by Twigg et al. (2018) [11]
and Tripathi et al. (2019) [12]. Strains MCTG107b and MCTG214(3b1) belong to the
genus Marinobacter and Pseudomonas, respectively. Chemical analysis revealed that the
biosurfactant produced from strain MCTG107b is a glycolipid and specifically a mixture of
rhamnolipid analogues. Similarly, MCTG214(3b1) strain was also found to synthesize a
biosurfactant comprised by rhamnolipid congener, mostly di-rhamnolipids. Importantly,
both the Pseudomonas sp. MCTG214(3b1) and Marinobacter sp. MCTG107b appeared to be
non-pathogenic as illustrated via the Galleria mellonella infection model [11,12].
Rhamnolipids are the most investigated biosurfactants of the glycolipid group [13].
They contain a hydrophilic group, consisting of either one or two rhamnose monosac-
charides linked, via a covalent bond, to a hydrophobic moiety, consisting of one or two
β-hydroxy fatty acids [11,14]. Rhamnolipids with one and two rhamnose monosaccharides
in the hydrophobic group are categorized as mono-rhamnolipids and di-rhamnolipids,
respectively. The bacterial cultivation process results in the production of a mixture of dif-
ferent rhamnolipid congeners, differing in the fatty acid saturation level, in the number of
rhamnose monosaccharides and in the length of the hydrophobic chain [14]. Several studies
reported that plant and bacteria-derived rhamnolipids exhibit anti-oxidant, anti-viral, and
anti-cancer properties [15–21].
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In this study, we investigated the toxicity profile of the biosurfactants produced by
these two novel strains, MCTG107b and MCTG214(3b1). For this, their free-radical scaveng-
ing activity was examined via the 2,2’-azino-bis (3-ethylbenzothiazoline-6-sulphonicacid)
(ABTS) and 2,2-diphenyl-1-picrylhydrazyl radical (DPPH) assays. Then, we investigated the
cytotoxicity profile of the biosurfactants in human skin and liver cell models by the alamar
blue and propidium iodide assays and compared them with synthetic industrial surfac-
tants. Finally, the mutagenic and anti-mutagenic potential of the new biosurfactants under
oxidative stress conditions were determined by the single cell gel electrophoresis assay.
2. Results
2.1. Cell-Free Radical Scavenging Activity of the Two Biosurfactants
The chemical composition of the biosurfactants produced by the novel bacterial
strains MCTG107b and MCTG214(3b1) have been previously described. Chemical analysis
studies revealed that the MCTG214(3b1) strain synthesizes biosurfactants comprised by
rhamnolipid congeners, mostly di-rhamnolipids [11] (Supplementary Materials, Table S1).
Similarly, the biosurfactants produced from strain MCTG107b are a mixture of rham-
nolipid analogues [12] (Supplementary Materials, Table S2). To investigate the in vitro
anti-oxidant properties of the MCTG107b and MCTG214(3b1) derived biosurfactants, es-
tablished methodologies were utilized based on the determination of total antioxidant
capacity (ABTS assay) and ability to scavenge (inhibit) free radical generation (DPPH
assay). Overall, none of the examined biosurfactants exhibited significant radical scaveng-
ing activity. Consequently, the IC50 values of the biosurfactants could not be accurately
estimated (Table 1). Specifically, at the highest concentration tested (1 mg/mL), MCTG107b
derived biosurfactant exhibited only 9.67 ± 3.27 and 14.84 ± 0.4% inhibition for DPPH
and ABTS, respectively (Table 2). Similarly, the MCTG214(3b1) derived biosurfactant ac-
counted for only negligible antioxidant capacity exhibiting 15.46 ± 4.03 and 10.52 ± 1.75%
inhibition at the highest concentration (1 mg/mL) for DPPH and ABTS, respectively. In
contrast, ascorbic acid, which was used as a positive control, exhibited significant radical
scavenging activity and its IC50 values were 25.97 ± 0.25 and 29.32 ± 0.17 for DPPH and
ABTS, respectively (Table 1).
Table 1. Radical scavenging activity of the novel biosurfactants by DPPH and ABTS assays. Data are
representative of mean values ± SD of the IC50 values. Three replicates were used per experiment.






Ascorbic acid 25.97 ± 0.25 29.32 ± 0.17
n.d.: Not determined.
Table 2. Free radical scavenging activity of the novel biosurfactants at the highest examined concen-
tration using the DPPH and ABTS assays. Data are representative of mean values ± SD of at least
three independent experiments. Three replicates were used per experiment.
Inhibition (%) at 1 mg/mL
DPPH ABTS
MCTG107b 9.67 ± 3.27 14.84 ± 0.4
MCTG214(3b1) 15.46 ± 4.03 10.52 ± 1.75
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2.2. Evaluation of In Vitro Cytotoxicity Profile of SAAs
Next, alamar blue and propidium iodide assays were used to examine the toxicity
profile of the biosurfactants, produced by MCTG107b and MCTG214(3b1), by determining
the levels of viable and dead cells in human immortalized keratinocyte (HaCaT; skin) and
hepatocyte (THLE-3; liver) cell lines. Levels of viable cells were determined by utilizing
the Alamar Blue assay. Cells were cultured in the presence of increasing concentrations
(0.25–3 mg/mL) of the biosurfactants for 24, 48, and 72 h. Then the viability of treated cells
was determined through the alamar blue assay in comparison to the control-untreated cells.
Overall, our data showed that the MCTG107b and MCTG214(3b1) derived biosurfactants
exhibit negligible cytotoxicity at concentrations up to 0.25 mg/mL in the skin cell line
(Figure 1). However, both biosurfactants were found to be cytotoxic to the HaCaT cells
at concentrations beyond 0.25 mg/mL (Figure 1). A similar pattern was observed when
utilizing the liver cell line model, as the biosurfactants appeared to be safe at concentrations
lower and equal to 0.25 mg/mL (Figure 2). On the contrary, when used at concentrations
higher than 0.25 mg/mL, both biosurfactants were highly cytotoxic, with viability being
significantly lower than 50% at 1 mg/mL after 48 and 72 h treatments (Figure 2). This
observation was also confirmed by the determination of EC50 values of both biosurfactants
for all incubation periods. More specifically, EC50 values for more extended exposure
periods (72 h) were lower compared to shorter ones (24 h), whereas it is obvious that
THLE3 were more sensitive compared to HaCaT cells with lower EC50 values (Figures 1c
and 2c). Moreover, we used the propidium iodide assay as another means of determining
cytotoxicity by monitoring the levels of dead cells. Similarly, to our previous findings, there
was an increase in the rates of dead cell population for both skin and liver models following
treatment with 0.25, 0.5, or 1 mg/mL of either biosurfactant (Figure 3). According to our
observations, cells incubated with the highest concentration (1 mg/mL) demonstrated the
highest elevation in dead cell levels in both cases. Once again, THLE3 were clearly more
sensitive (Figure 3c,d) in contrast to HaCaT cells which were considerably more resistant
(Figure 3a,b). Based on our results, we selected 0.25 mg/mL as a safe concentration for the
subsequent experiments to ensure high cell viability.
Finally, in order to assess the safety profile of the MCTG107b and MCTG214(3b1)
biosurfactants, we exposed HaCaT and THLE3 cells to two synthetic surfactants that are
widely used in, for example, cosmetics and pharmaceuticals applications, namely Cro-
dasinic LS30 and Texapon N70. It should be noted that the MCTG107b and MCTG214(3b1)
derived biosurfactants (rhamnolipid congeners) do not have similarities in their chemical
structure with Crodasinic LS30 and Texapon N70 (Supplementary material, Tables S1 and
S2 and Figure S1). Biosurfactants are chemically more complex molecules compared to
their synthetic counterparts. Crodasinic LS30 and Texapon N70 are aqueous mixtures of
sodium lauroyl sarcosinate (30% w/v) (Supplementary Materials, Figure S1a) and sodium
lauryl ether sulfate (70% w/v) (Supplementary Materials, Figure S1b), respectively. Both
cell lines were treated with various concentrations of the surfactant, 0.0015–0.03 mg/mL
for Crodasinic LS30 (Figure 4a,c), and 0.0007–0.007 mg/mL for Texapon N70 (Figure 4b,d).
Viability was determined using the alamar blue assay (described above) in the case of
the biosurfactants for the same incubation periods (24, 48, and 72 h). Our findings indi-
cated that both industrial surfactants were capable of inducing cytotoxicity at much lower
concentrations (>0.002 mg/mL) compared to the biosurfactants (>0.5 mg/mL), which is
supported by the EC values as well (Figure 4e). These results suggest that the biosurfactants
could potentially be a safer alternative for the most common surfactants used currently
in industry.
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Figure 1. Cytotoxicity profile of MCTG107b (a) and MCTG214(3b1) (b) derived biosurfactants in the HaCat in vitro skin 
model. HaCat cells were treated for 24, 48, or 72 h with increasing concentrations (0.25–3 mg/mL) of (a) MCTG107b and 
Figure 1. Cytotoxicity profile of CTG107b (a) and CTG214(3b1) (b) derived biosurfactants in the HaCat in vitro skin
model. HaCat cells were treated for 24, 48, or 72 h with increasing concentrations (0.25–3 mg/mL) of (a) MCTG107b and (b)
MCTG214(3b1). Table showing EC50 values for all incubation periods. (c) The viability of cells was determined by utilizing
the Alamar blue assay. The results are shown as the mean ± SD and are representative from three independent experiments.
Note: ** p < 0.01, *** p < 0.001 vs. control (untreated cells).
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model. THLE3 cells were incubated with increasing concentrations (0.25–3 mg/mL) of (a) MCTG107b and (b) MCTG214(3b1)
for 24, 48, or 72 h. Table showing EC50 values for all incubation periods. (c) The viability of cells was determined by utilizing
the alamar blue assay. The results are shown as the mean ± SD and are representative from three independent experiments.
Note: *** p < 0.001 vs. control (untreated cells).
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Figure 3. Deter ination of dead cell populations after exposure to CTG107b (a,c) and CTG214(3b1) (b,d) derived
biosurfactants in the HaCaT and THLE3 in vitro skin and liver models, respectively. Both cell lines were incubated with
increasing concentrations (0.25–3 mg/mL) of (a,c) MCTG107b and (b,d) MCTG214(3b1) for 24, 48, or 72 h. Levels of
dead cells were determined by utilizing the propidium iodide assay. The results are shown as the mean ± SD and are
representative from three independent experiments. Note: ** p < 0.01, *** p < 0.001 vs. control (untreated cells).
2.3. Assessment of Anti-Mutagenic Potential of SAAs In Vitro
For evaluating the anti-mutag nic potenti l of th biosurfactants, the human melanoma
A375 and hepatoma Hep3B cell line models have been used. Specifically, A375 and Hep3B
c lls were pre-in ubated with 0.25 mg/mL of biosurfactants for 48 h. C lls wer then either
treated with H2O2 (15 min, 5 µM H2O2 for A3 5 and 2.5 µM H2O2 for Hep3B) or irr di-
ated with UVB (22 mJ/cm2 for A375 and 27 mJ/cm2 for Hep3B) and subsequently DNA
damage levels (single strand DNA breaks SSBs) were evaluated by the alkaline single cell
gel electrophoresis (comet) assay. UVB and H2O2 were utilized as two different genotoxic
agents, and the specific conditions used for each cell line were chosen to approximately
double DNA damage levels. Our results indicate that in A375 cells, the MCTG107b derived
biosurfactant slightly reduced both the UVB and H2O2-induced DNA damage (Figure 5).
However, MCTG214(3b1) derived biosurfactants reduced the H2O2-induced DNA damage,
but increased the UVB-induced DNA damage levels (Figure 5). Similar results were, in
general, obtained in the case of Hep3B cells, where pre-incubation with both biosurfactants
inhibit DNA damage in all conditions tested (Figure 6). Overall, MCTG107b derived biosur-
factant exhibited higher geno-protective properties, in comparison to the MCTG214(3b1)
produced biosurfactant, however, these effects were statistically non-significant, and thus
no anti-mutagenic activity could be established.
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2.3. Assessment of Anti-Mutagenic Potential of SAAs In Vitro 
For evaluating the anti-mutagenic potential of the biosurfactants, the human mela-
noma A375 and hepatoma Hep3B cell line models have been used. Specifically, A375 and 
Hep3B cells were pre-incubated with 0.25 mg/mL of biosurfactants for 48 h. Cells were 
then either treated with H2O2 (15 min, 5 μM H2O2 for A375 and 2.5 μM H2O2 for Hep3B) 
or irradiated with UVB (22 mJ/cm2 for A375 and 27 mJ/cm2 for Hep3B) and subsequently 
DNA damage levels (single strand DNA breaks SSBs) were evaluated by the alkaline sin-
gle cell gel electrophoresis (comet) assay. UVB and H2O2 were utilized as two different 
genotoxic agents, and the specific conditions used for each cell line were chosen to ap-
proximately double DNA damage levels. Our results indicate that in A375 cells, the 
MCTG107b derived biosurfactant slightly reduced both the UVB and H2O2-induced DNA 
damage (Figure 5). However, MCTG214(3b1) derived biosurfactants reduced the H2O2-
induced DNA damage, but increased the UVB-induced DNA damage levels (Figure 5). 
Similar results were, in general, obtained in the case of Hep3B cells, where pre-incubation 
with both biosurfactants inhibit DNA damage in all conditions tested (Figure 6). Overall, 
MCTG107b derived biosurfactant exhibited higher geno-protective properties, in compar-
ison to the MCTG214(3b1) produced biosurfactant, however, these effects were statisti-
cally non-significant, and thus no anti-mutagenic activity could be established. 
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Figure 6. Anti-mutagenic properties of SA s in an in vitro cancer liver model. Hep-3B cells were pre-
incubated for 48 h with 0.25 mg/mL of MCTG107b/MCTG214(3b1) and subsequently irradiated with
27 mj/cm2 UVB or treated with 2.5 µM of H2O2 for 15 min. The DNA damage was then determined
through alkaline single cell gel electrophoresis assay. Data represent the mean ± SD fold-change
of DNA damage levels co pared to the control cells. At least three ind pendent exp riments were
perfor ed for each condition tested. N te: ** p < 0.01, *** p < 0.001 vs. control (untreated cells).
3. Discussion
Surface acting agents are amphipathic molecules with the ability to adsorb to interfaces
of gas-liquid, liquid-liquid, as well as solid-liquid [1]. Due to their unique properties, they
have a crucial role in pharmaceutical, detergent, cosmeceutical, and food industry [3].
However, the extensive use of t ese synthetic, larg ly non-degradable products c mes with
several disadvantages, most of which ar associated with high environmental risks and/or
increased toxicity. Natur l-derived biosurfact nts constitute an environmentally- friendly,
no -toxic alternative that could substitute, to a certain extent, the c rrently used chemical
SAAs [4].
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Various different microorganisms, mainly species of yeast and bacteria, have been
successfully used to produce biosurfactants of various chemical properties. For instance,
species of the genera Bacillus and Pseudomonas are the most common bacterial biosurfactant
producers [22]. Nevertheless, their use is restricted, mainly due to their high pathogenicity
that makes them inappropriate for use in food related products [23]. In contrast, yeast,
such as Yarrowia lipolytica and Saccharomyces cerevisiae, exhibit a non-pathogenic profile,
thus are considered a safer choice for certain applications [5].
In the last three decades, the marine environment has emerged as a valuable source for
discovering novel biosurfactant-producing microorganisms, including those that produce
these biomolecules with novel properties and molecular structures [4]. Specifically, a
great number of biosurfactants have been identified from bacterial groups, like Halomonas,
Alcavinorax, Bacillus, Acinetobacter, and Pseudomonas that developed in contaminated waters
near oil spills [24,25].
In MARISURF EU Horizon 2020 project, several biosurfactants were identified from a
novel collection of marine bacteria and were studied with respect to their surface tension
reduction and other properties. From this project, two biosurfactant producing strains were
identified, Marinobacter sp. strain MCTG107b and Pseudomonas sp. strain MCTG214(3b1).
The biosurfactants produced by these organisms were identified as rhamnolipid congeners,
consisting mainly of di-rhamnolipids, while notably, neither of these Marinobacter and
Pseudomonas strains were found to be pathogenic [11,12].
Our goal in this study was to further characterize their bioactive properties and
specifically to determine their toxicity profile, as well as to investigate their potential anti-
oxidant and anti-mutagenic activities. Our hypothesis, on the potential biological actions of
these novel biosurfactants, is based on previous studies reporting that many biosurfactants
possess multifunctional activities (e.g., anti-oxidant, anti-cancer, and anti-aging) [9,10].
For instance, He et al. (2016) examined the direct anti-oxidant potential of four different
polysaccharides through ABTS assay and reported that all the examined biosurfactants
exhibited strong free radical scavenging activity [26]. Similarly, the radical scavenging
ability of a biosurfactant derived from the brown seaweed Sargassum polycystum was
determined via DPPH assay by Palanisamy et al. (2017) [27]. Their results indicated that
the biosurfactant showed 61.22% DPPH radical inhibition at 1 mg/mL, while L-ascorbic
acid exhibited 2.30% inhibition at the same concentration (1 mg/mL) [27].
In our study, we applied a similar methodology to determine the cell-free direct
anti-oxidant activity of the two novel biosurfactants. The anti-oxidant properties of the
biosurfactants are crucial for food products considering their susceptibility to oxidation,
which is responsible for food deterioration [9,28]. Our data indicated that none of the
biosurfactants appeared to have a significant free-radical scavenging ability, as indicated
by both DPPH and ABTS assays. Previously published data have demonstrated the direct
anti-oxidant capacities of certain marine-derived rhamnolipid biosurfactants. Haque et al.
(2020) showed that rhamnolipid congeners synthesized by Marinobacter litoralis MB15
exhibits 72.6% and approximately 40% DPPH radical scavenging activity at 5 mg/mL and
1 mg/mL concentrations, respectively [15]. The discrepancies observed with our study
could be attributed to the different chemical composition of the rhamnolipids analogues.
Specifically, the Marinobacter litoralis MB15 derived biosurfactant mainly consists of the
mono-rhamnolipid congener Rha-C10-C10, while the biosurfactants examined in this study
are mainly composed by Rha-Rha-C10-C10, Rha-Rha-C10, and Rha-Rha-C10-C10CH3
analogues [11,12].
Abdollahi et al. (2020) [16] also investigated the anti-oxidant capacity of the Pseu-
domonas aeruginosa MN1 produced rhamnolipid biosurfactant via DPPH and ferric re-
ducing antioxidant power (FRAP). The biosurfactant exhibited substantial reducing and
free-radical scavenging inhibiting potential, nevertheless the rhamnolipid biosurfactant
in this study was examined at concentrations significantly higher than the concentrations
of the biosurfactants that we applied [16]. Specifically, the IC50 value in DPPH assay for
the Pseudomonas aeruginosa MN1 derived biosurfactant was 2.277 mg/mL (4.15 mM with
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a molecular weight of 548.71 Da), whereas the biosurfactants in our study were used
at concentrations up to 1 mg/mL, mainly due to insolubility issues. Additionally, the
biosurfactant’s major constituent was a Rha-C10-C10 mono-rhamnolipid, so the different
compositions among the biosurfactants does not allow the critical comparison between the
two studies [16,29].
Another important issue in considering the utilization of biosurfactants in food and
cosmetic products is their safety profile. For this reason, we next investigated the cytotox-
icity of the novel biosurfactants against the human skin (HaCaT) and the liver (THLE3)
cell lines by utilizing the alamar blue and propidium iodide assays. The selection of
these models was based on the applications of the biosurfactants in personal care and
food industry. Specifically, skin and liver are the main two organs immediately exposed
to the biosurfactants following oral administration of a dietary agent or application of
a cosmeceutical product. Our results demonstrated that the biosurfactants were safe at
concentrations up to 0.25 mg/mL, while they exhibit significant cytotoxicity at concentra-
tions 0.25–3 mg/mL. Few data are available regarding the toxicity profile of rhamnolipid
biosurfactants on skin and liver cell models. In particular, a previous report by Haque et al.
(2020) describes the toxicity of the Marinobacter litoralis MB15 synthesized rhamnolipid
biosurfactant against a mouse fibroblast cell model. Briefly, L292 fibroblast cells were
treated with 0.05–0.25 mg/mL of the examined biosurfactant for 24 and 48 h, and then the
remaining cell viability was determined by the MTT assay. In agreement with our results,
rhamnolipid extract demonstrated a safe profile at all conditions tested, as treatment of
L292 cells with 0.25 mg/mL for 48 h resulted in 84.7% viability in comparison to the control
cells [15].
A number of additional studies also investigate the cytotoxicity profile of rhamnolipid
biosurfactants in cancer cell models [20,21,30]. For instance, Rahimi et al. (2019) [30]
showed, utilizing the MTT assay, that two Pseudomonas aeruginosa MR01 derived rham-
nolipid biosurfactants exhibited enhanced antiproliferative activity against breast cancer
MCF-7 cells with IC50 values of 25.87 µg/mL and 31.00 µg/mL, respectively [30]. Along
these lines, Pseudomonas aeruginosa B189 rhamnolipid exhibited significant cytotoxicity
against MCF-7 cells, with a minimum inhibitory concentration of 6.25 µg/mL [21]. In an at-
tempt to further investigate the potential of the two biosurfactants to be used for industrial
purposes as an alternative to current synthetic substances, we selected two widely used
surfactants, Crodasinic LS30 and Texapon N70, to compare their effects against the natural
derived ones. Crodasinic LS30 is a 30% (w/v) mixture of sodium N-lauroylsarcosinate,
while Texapon N70 a 70% (w/v) mixture of sodium lauryl ether sulfate. Both of them
are very well-known anionic surfactants used most commonly in cosmetics, detergents,
pharmaceutics, and other products. Our findings showed that both synthetic surfactants
appeared to be remarkably more cytotoxic compared to the biosurfactants as their EC50 val-
ues were much lower. This finding does not come as a surprise considering the general low
toxicity of biosurfactants compared to synthetic SAAs [31,32]. This could be explained on
the basis that biosurfactants are derived from biological systems, thus increased biological
toxicity would have been detrimental for the organisms producing them. Biosurfactants
are in general considered promising replacements of synthetic SAAs due to their low
toxicity and ecotoxicity, high biodegradability and compatibility with biological systems
and their excellent surface active properties [9,33,34]. Sodium lauryl sulfate (SLS), another
anionic synthetic surfactant, has been shown to induce the levels of intracellular ROS in
HaCaT and reconstructed human epidermal equivalent models by interacting with cellular
membranes, therefore suggesting a potent cause for increased skin roughness in response
to SLS exposure [35]. Results from a different study demonstrated that SLS caused a
higher skin irritation potential (zein value) compared to sodium coco sulfate (SCS) and
induced a metabolic reduction in HaCaT cells [36]. Therefore, our study provides further
evidence for the promising characteristics of natural derived surfactants and supports their
future exploitation.
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Finally, we investigated the potential anti-mutagenic capacity of the novel biosurfac-
tants via single cell gel electrophoresis assay. Importantly, the biosurfactants did not exhibit
any mutagenic activity. On the contrary, a pattern indicating minor anti-mutagenic activity
was observed in most conditions tested in melanoma (A375) and hepatoma (Hep-3B) cell
lines. Nevertheless, this observation is not statistically significant, thus no accurate conclu-
sion can be made at this point. In general, our results are in accordance with previously
published studies. For instance, Andreadou et al. (2016) [37] have reported that a Thermus
thermophilus produced rhamnolipid managed to effectively protect human lymphocytes
from the genotoxic effects of camptothecin, as demonstrated by the Sister Chromatin Ex-
changes assay (SCEs), in a statistically significant manner [37]. However, in contrast to
our data, the biosurfactant also exhibited a certain mutagenic activity in the absence of
camptothecin [37]. Furthermore, Pseudomonas putida derived mono-rhamnolipid biosurfac-
tants exhibited no genotoxicity when tested via the Ames fluctuation assay in a study by
Johann et al. [38].
In conclusion, the biosurfactant produced by these novel isolates Marinobacter strain
MCTG107b and Pseudomonas strain MCTG214(3b1), exhibited a relatively safe profile
including low cytotoxicity and no genotoxic activity, while no anti-oxidant activity was
demonstrated. A slight anti-mutagenic effect was demonstrated, however additional
experiments are required to clarify their potential cytoprotective properties. In general,
our results were promising in relation with the commercial exploitation of rhamnolipids
biosurfactants in food and cosmetic industry.
4. Materials and Methods
4.1. Materials
The biosurfactants were provided by our project partners from Ulster University as
part of the MARISURF EU Horizon 2020 project. The extraction and purification methods
were described in detail previously [11,12]. The human cell lines were obtained from the
American Type Culture Collection (ATCC, Rockville, MD, USA). Dulbecco’s Modified
Eagle’s Medium (DMEM, high glucose), penicillin/streptomycin, fetal bovine serum, and
phosphate-buffered saline were obtained from Biosera (Boussens, France). BEGM medium
was from Lonza (Lonza/Clonetics Corporation, Walkersville, MD, USA) DPPH, ABTS,
and low melting point agarose were purchased from Sigma-Aldrich (BioUltra, Darmstadt,
Germany). Resazurin sodium salt and propidium iodide were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Crodasinic LS30 and Texapon N70 were supplied by DeWolf
Chemical (Warwick, RI, USA).
4.2. DPPH and ABTS Assays
ABTS and DPPH assays were carried out as previously described [39]. For DPPH,
the extracted biosurfactants were dissolved in methanol to a range of concentrations
(0.05–1 mg/mL). A 20 µL volume of each concentration was then added to 180 µL of a
300 µM methanolic solution of DPPH radical for 15 min, at RT in the dark. Twenty µL
of the biosurfactant solvent mixed with 180 µL of DPPH radical solution was used as a
blank. Subsequently, the absorbance of each sample (at 540 nm) was measured by an ELISA
plate reader (EnSpire Multimode Plate Reader, Perkin Elmer, Waltham, MA, USA). The
radical scavenging activity was estimated as % inhibition for each condition tested with
the following formula:
% DPPH radical scavenging activity = 100 × [(ODblank − ODsample)/ODblank)]. (1)
For ABTS assay, 2.45 mM potassium persulfate was added to 7 mM ABTS for 16 h,
under darkness to induce the formation of the ABTS cation (ABTS+). Then, 180 µL of
the ABTS·+ solution were mixed with 20 µL of biosurfactant dilutions (0.05–1 mg/mL),
prepared in methanol, for 30 min, at room temperature. As a blank, 20 µL of biosurfactant’s
solvent were mixed with 180 µL of the ABTS·+ solution that was used. The absorbance of
each sample at 734 nm was determined using an Elisa plate reader (EnSpire Multimode
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Plate Reader, Perkin Elmer, Waltham, MA, USA) and the antioxidant capacity was esti-
mated as % inhibition of the cation ABTS·+, for each concentration tested, by using the
following formula:
% ABTS·+ radical scavenging activity = 100 × [(ODblank − ODsample)/ODblank)]. (2)
All samples were examined in three replicates. Ascorbic acid, a known antioxidant
substance, was used as a positive control for both assays.
4.3. Cell Culture and Treatments
Human immortalized keratinocyte HaCaT cell line, melanoma A375 cell line and
hepatocellular carcinoma Hep-3B cell line were all maintained in Dulbecco’s Modified
Eagle’s Medium high glucose, supplemented with 10% Fetal Bovine Serum, 100 U/mL
penicillin, and 100 µg/mL streptomycin, while liver THLE3 cell line was maintained in
BEGM medium supplemented with 5 ng/mL EGF, 70 ng/mL Phosphoethanolamine and
10% fetal bovine serum. All cell lines were cultured at 37 ◦C, in a 5% CO2 humidified
atmosphere. Cells were grown as monolayers and were sub-cultured when they reached
approximately 90% confluency. For all cell treatments, biosurfactants were initially pre-
pared in methanol at a concentration of 400 mg/mL and then further diluted in complete
cell culture medium to the respective working concentration.
4.4. Cytotoxicity Assays
The cytotoxicity profile of the biosurfactants was assessed through the alamar blue
assay and the propidium iodide assay.
For alamar blue assay, the proper number of HaCaT/THLE-3 cells were seeded into
96-well plates and incubated overnight. On the next day, they were treated with a range
of concentrations of the biosurfactants (0.25–3 mg/mL) at a final volume of 100 µL for 24,
48, and 72 h. Following the treatments, 10 µL of 1 mg/mL resazurin reagent were added
into each well and mixed by gentle shaking. Samples were incubated at 37 ◦C for 4 h
and then the absorbance was recorded at 570 nm and 600 nm (reference wavelength) by
using a Spark multimode plate reader (Tecan, Switzerland). The levels of viable cells were
estimated, and cell viability was expressed as percentage of control (untreated) cells. Five
replicates (n = 5) of each condition were used in each experiment.
For the propidium iodide assay, the proper number of HaCaT or THLE-3 cells were
seeded into 96-well plates, and on the following day they were treated with 0.25, 0.5, and
1 mg/mL of the biosurfactants (prepared in complete culture media) at a final volume
of 100 µL. At the end of 24, 48, and 72 h incubation periods, 100 µL of 5 µM propidium
iodide (diluted in PBS) was added into each well for 30 min at 37 ◦C. Fluorescence was
then monitored at 530 nm excitation/620 nm emission and the levels of dead cells were
determined based on the detected increase in fluorescence values. As a positive control,
cells were treated with 0.2% Triton X-100 in complete medium for 15 min to induce cell
death by breakage of their cellular membrane. Levels of dead cells were expressed as the
percentage of positive control cells (100% of cells were dead). Five replicates (n = 5) of each
condition were used in each experiment.
4.5. Single Cell Gel Electrophoresis Assay (Comet Assay)
The comet assay was performed as described previously [40]. Briefly, 2 × 105 of
A375/Hep3B cells were seeded on 60 mm plates and cultured for 24 h. Then, cells were
pre-treated with 0.25 mg/mL of the biosurfactants, prepared in culture media, for 48 h.
Subsequently, cells were either irradiated with UVB in PBS (22 mJ/cm2 or 27 mJ/cm2
for A375 and Hep3B respectively) using a Bio-Link BLX254 Crosslinker (Vilber Lourmat,
Marne-la-Vallée, France) or treated for 15 min with H2O2 (5 µM or 2.5 µM H2O2 for A375
and Hep3B, respectively). Cells were then collected though trypsinization, washed with
PBS and suspended (2 × 104 cells) into 1 mL low melting point agarose, prepared in PBS.
Cell loaded agarose was then placed onto microscope slides precoated with a thin layer
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of 1% low melting point agarose. Slides were subsequently immersed in lysis solution
(1.2 M NaCl, 100 mM Na2EDTA, 0.1% sodium lauryl sarcosinate, 0.26 M NaOH, pH∼13) at
4 ◦C, under darkness. Following an 1 h incubation, slides were washed with rinse solution
(0.03 M NaOH, 2 mM Na2EDTA, pH ~12.3) at RT for 20 min. Slides were subjected to
electrophoresis (in the rinse solution) for 25 min at 13V, and then washed in dH20 and
stained with 10 µg/mL propidium iodide for 20 min. Finally, following a final wash
with dH20, they were processed for observation on a Nikon ECLIPSE E200 fluorescence
microscope. For estimating DNA damage, 100 comets were analyzed for each slide. Each
cell was scored as class 0, 1, 2, 3, or 4 on the basis of the DNA damage levels visualized as
“tail”. Each cell was assigned with in regard to its class and the total score of 100 comets
ranged from 0 (100% comets being in class 0) up to 400 (100% comets of class 4).
4.6. Statistical analysis
Statistical analysis of the experiments and graphs were performed with either Graph-
Pad Prism 5 or Sigma Plot Software v.10. Results are expressed as the mean ± SD of at least
three independent experiments performed in three or five replicates. Statistical analysis
between two samples were performed by two-tailed Student’s t-test. Analysis of two
variables among multiple groups was performed with a two-way ANOVA, followed by
Tukey’s multiple comparison test. A p ≤ 0.05 was considered as statistically significant.
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